Human clinical trials – a crucial step in the life sciences sector – inevitably come with certain liabilities. Companies embarking on this complex journey must navigate unique exposures that are significantly amplified during such trials. Understanding and managing these associated risks is paramount not just for regulatory compliance, but also for the overall company health. It involves a holistic approach, right from the identification of potential hazards to the procurement of suitable product liability insurance. JDSupra recently hosted a webinar to highlight these nuances and provide insights into managing product liability effectively during human clinical trials.
One critical aspect to mitigate risks is to establish a global clinical trial product liability insurance program. It serves as a strategy to general liability, covering not just the organizations but also the principal investigators, representatives, employees and volunteers involved.
Several types of insurance policies are typically explored and leveraged during clinical trials. The choice often depends on the nature of the trial, the regulatory requirements in various geographical jurisdictions, the study design, and recruitment procedures. Plotting out an insurance program requires thorough consideration of all these variables.
Insurance underwriting for clinical trials is a multi-tiered process. It begins with the underwriting data requirements – a detailed exercise to understand the insurance needs specific to the trial. Beyond policy underwriting, setting up appropriate timelines is another important factor. Insurance companies usually have a framework for these processes, which involve proposal submission, risk assessment, and policy issuance.
The payment terms and procedures should also be considered carefully. The wisdom to predict and accommodate potential cost escalations or other unexpected expenses can be vital during lengthy clinical trials. Crafting these essential aspects into contingency plans forms the backbone of successful trial operations.
The webinar by Woodruff Sawyer also throws light on other factors to consider while structuring a product liability insurance program. The comprehensive overview serves as an invaluable guide to companies hoping to tread on the challenging yet promising path of human clinical trials.